Kalevi Kurkijarvi is Director at FIBROGEN INC (FGEN). They have made 38 open-market trades across 1 company since 2017, most recently 2021-05-26.
CIK 0001621333
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 38 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FGEN | 37,800 | $367K |
Shares reported on the most recent Form 4, priced at the 2021-05-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FGEN | SELL | 2021-02-17 | 2021-02-19 | $52.36 | $584K | -33.5% | -34.1% | -58.8% |
| FGEN | SELL | 2021-01-19 | 2021-01-21 | $43.38 | $521K | +11.4% | +16.7% | -52.4% |
| FGEN | SELL | 2021-01-14 | 2021-01-15 | $40.04 | $480K | +12.9% | +22.5% | -55.5% |
| FGEN | SELL | 2020-12-28 | 2020-12-30 | $40.40 | $481K | +4.4% | +27.5% | -17.7% |
| FGEN | SELL | 2020-02-10 | 2020-02-12 | $42.69 | $256K | -4.5% | -29.8% | -16.3% |
| FGEN | SELL | 2020-01-06 | 2020-01-08 | $42.66 | $512K | -0.5% | +0.2% | -21.0% |
| FGEN | SELL | 2019-12-09 | 2019-12-12 | $47.50 | $285K | -3.6% | -12.1% | -25.6% |
| FGEN | SELL | 2019-11-07 | 2019-11-08 | $38.27 | $459K | -9.8% | +14.0% | +8.8% |
| FGEN | SELL | 2019-10-07 | 2019-10-09 | $36.73 | $441K | +7.0% | +13.5% | +16.4% |
| FGEN | SELL | 2019-09-09 | 2019-09-10 | $40.95 | $246K | -3.7% | -11.6% | +15.3% |
| FGEN | SELL | 2019-08-05 | 2019-08-07 | $45.22 | $271K | +0.7% | -7.6% | -11.4% |
| FGEN | SELL | 2019-07-08 | 2019-07-10 | $42.60 | $256K | +5.4% | +2.0% | -19.8% |
| FGEN | SELL | 2019-06-06 | 2019-06-07 | $37.86 | $454K | +14.9% | +10.3% | +8.5% |
| FGEN | SELL | 2019-05-08 | 2019-05-10 | $45.89 | $507K | +1.9% | +14.2% | +33.0% |
| FGEN | SELL | 2019-04-15 | 2019-04-17 | $48.09 | $192K | +0.9% | -22.8% | +0.3% |
| FGEN | SELL | 2019-04-08 | 2019-04-10 | $52.99 | $394K | -11.7% | -32.9% | -17.4% |
| FGEN | SELL | 2018-12-19 | 2018-12-21 | $41.32 | $165K | +13.9% | +29.1% | +39.6% |
| FGEN | SELL | 2018-11-15 | 2018-11-16 | $39.77 | $159K | +4.8% | -3.3% | +41.3% |
| FGEN | SELL | 2018-10-18 | 2018-10-19 | $55.42 | $222K | -19.0% | -25.9% | -4.0% |
| FGEN | SELL | 2018-09-17 | 2018-09-18 | $58.86 | $235K | +6.1% | -4.6% | -31.9% |
| FGEN | SELL | 2018-08-16 | 2018-08-17 | $60.42 | $390K | -0.5% | -7.2% | -34.1% |
| FGEN | SELL | 2018-07-19 | 2018-07-20 | $64.35 | $515K | -2.4% | -8.9% | -16.1% |
| FGEN | SELL | 2018-06-18 | 2018-06-20 | $58.19 | $233K | -0.6% | +2.2% | -9.9% |
| FGEN | SELL | 2018-05-17 | 2018-05-18 | $51.83 | $207K | +5.2% | +16.5% | +18.1% |
| FGEN | SELL | 2018-04-19 | 2018-04-20 | $47.69 | $191K | +1.2% | +12.8% | +38.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.